Immune Checkpoint Inhibitors and Hemophagocytic Lymphohistiocytosis: Disproportionality Analysis from FAERS

---

Güzel S. S., Atak S., Çiçek E., Demirci N. S., Alan Ö.

Esmo Immuno-Oncology 2025, December 2025

• Award Scope: Award from Scientific / Professional Studies
• Award Type: Kongre, Konferans, Festival veya Sempozyum Kurullarınca Verilen Ödül
• Award Country: England
• Awarding Organization: Esmo Immuno-Oncology 2025
• Research Areas: Health Sciences
• Award Date: December 2025
• Description:

   ESMO MERİT AWARD